Featured Products
Hot Products
ONLINE INQUIRY
Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells (Untreated)
Cat.No.: CSC-C4548X
Species: Human
Source: Peripheral Blood; Blood
Cell Type: B Cell; Lymphocyte
- Specification
- Q & A
- Customer Review
Cat.No.
CSC-C4548X
Description
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.
The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.
The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.
Species
Human
Source
Peripheral Blood; Blood
Cell Type
B Cell; Lymphocyte
Disease
Chronic Lymphocytic Leukemia (CLL); Cancer
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.
Ask a Question
Write your own review
Related Products